Literature DB >> 21436360

Exercise training in heart failure: from theory to practice. A consensus document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation.

Massimo F Piepoli1, Viviane Conraads, Ugo Corrà, Kenneth Dickstein, Darrel P Francis, Tiny Jaarsma, John McMurray, Burkert Pieske, Ewa Piotrowicz, Jean-Paul Schmid, Stefan D Anker, Alain Cohen Solal, Gerasimos S Filippatos, Arno W Hoes, Stefan Gielen, Pantaleo Giannuzzi, Piotr P Ponikowski.   

Abstract

The European Society of Cardiology heart failure guidelines firmly recommend regular physical activity and structured exercise training (ET), but this recommendation is still poorly implemented in daily clinical practice outside specialized centres and in the real world of heart failure clinics. In reality, exercise intolerance can be successfully tackled by applying ET. We need to encourage the mindset that breathlessness may be evidence of signalling between the periphery and central haemodynamic performance and regular physical activity may ultimately bring about favourable changes in myocardial function, symptoms, functional capacity, and increased hospitalization-free life span and probably survival. In this position paper, we provide practical advice for the application of exercise in heart failure and how to overcome traditional barriers, based on the current scientific and clinical knowledge supporting the beneficial effect of this intervention.

Entities:  

Mesh:

Year:  2011        PMID: 21436360     DOI: 10.1093/eurjhf/hfr017

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  163 in total

1.  Therapeutic efficacy of intensified walk training under the electrocardiogram telemetry in stroke induced lower limb dysfunction patients with heart failure.

Authors:  Dantong Shen; Huai Huang; Hui Yuan; Shuilin Ye; Min Li; Jing Gu; Zhiwei Wang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

Review 2.  [Exercise training in the therapy of heart diseases: Current evidence and future options].

Authors:  S Schwarz; A Boscheri; J Christle; A Duvinage; K Esefeld; H Fricke; N Pitsch; A Pressler; M Weichenberger; M Halle
Journal:  Herz       Date:  2016-03       Impact factor: 1.443

Review 3.  Telemedicine and telerehabilitation: current and forthcoming applications in haemophilia.

Authors:  Elena A Boccalandro; Giuseppe Dallari; Pier Mannuccio Mannucci
Journal:  Blood Transfus       Date:  2019-02-04       Impact factor: 3.443

4.  [Exercise training as a key component of heart failure therapy].

Authors:  M Dörr; M Halle
Journal:  Herz       Date:  2015-04       Impact factor: 1.443

Review 5.  [Cardiovascular prevention and regular physical exercise : Activity and training as the true "polypill"].

Authors:  H Löllgen; N Bachl
Journal:  Herz       Date:  2016-12       Impact factor: 1.443

6.  Creatinine excretion rate, a marker of muscle mass, is related to clinical outcome in patients with chronic systolic heart failure.

Authors:  Jozine M ter Maaten; Kevin Damman; Hans L Hillege; Stephan J Bakker; Stefan D Anker; Gerjan Navis; Adriaan A Voors
Journal:  Clin Res Cardiol       Date:  2014-07-03       Impact factor: 5.460

7.  Exercise training in chronic heart failure: mechanisms and therapies.

Authors:  M F Piepoli
Journal:  Neth Heart J       Date:  2013-02       Impact factor: 2.380

Review 8.  High-intensity aerobic interval exercise in chronic heart failure.

Authors:  Philippe Meyer; Mathieu Gayda; Martin Juneau; Anil Nigam
Journal:  Curr Heart Fail Rep       Date:  2013-06

Review 9.  The potential role of endogenous bacteriophages in controlling invading pathogens.

Authors:  Andrzej Górski; Beata Weber-Dabrowska
Journal:  Cell Mol Life Sci       Date:  2005-03       Impact factor: 9.261

Review 10.  [Depression and heart failure - a twofold hazard? : Diagnosis, prognostic relevance and treatment of an underestimated comorbidity].

Authors:  J Wallenborn; C E Angermann
Journal:  Herz       Date:  2016-12       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.